The Trade Desk's new CEO option grant is being read as a bet on an eightfold rerating. The filings support a different reading. The grant is the latest entry in a compensation habit that, at today's market value, costs shareholders close to a tenth of the company every year. The option repricing proxy now on file turns that habit into a guarantee. Once a board shows it will reset strikes after a collapse, including for its top executives, a fresh performance grant stops telling investors much about what the board expects. It mostly tells them what the board is willing to pay.
The Compensation Bill Is the Real Disclosure
Start with the figure that headline-driven coverage skips. Per The Trade Desk's FY2025 10-K, the company recorded $490.6 million of stock-based compensation against $2.9 billion of revenue, about 16.9 cents of every revenue dollar. That expense hits GAAP operating income, which came in at $589.3 million for a 20.3% margin. It does not hit free cash flow, which reached $795.7 million because the cash flow statement adds non-cash compensation back.
The usual bull screen ends at that FCF figure. Against a market capitalization of roughly $5.7 billion at a share price near $12.09 in early October 2026, $795.7 million looks like a 14% free cash flow yield on a profitable, net-cash ad-tech platform. Subtract the stock compensation and the picture changes. FCF net of SBC is about $305 million, a yield closer to 5.4%. Equity compensation absorbed roughly 62% of FY2025 free cash flow.
The more useful comparison is to the current equity value. When FY2025 compensation was granted and expensed, the stock traded far higher than it does now. If the company keeps compensating in dollar terms at anything near FY2025 levels, the annual bill equals about 8.6% of today's market cap. Paying a fixed dollar amount of equity into a collapsed share price means issuing many more shares for the same compensation. Boards in that position often face a choice between cutting the dollar value of grants and absorbing heavier dilution. The repricing proxy shows which way this board leans: it is protecting the value of what it has already handed out.
A Repricing That Reaches the Corner Office
An option repricing is the board asking shareholders to lower the strike on options that went underwater. The argument offered is retention: deeply out-of-the-money options stop motivating anyone, and talented employees leave. In a competitive engineering labor market that argument has some force for rank-and-file staff.
The asymmetry is the problem. If The Trade Desk had risen tenfold, no employee would have returned part of the windfall for being overpaid in hindsight. A repricing gives holders a second attempt after shareholders have already absorbed the loss. The commentator who flagged the proxy, the author of Yet Another Value Blog, calls it a "heads I win; tails I don't lose" structure. The description fits.
What separates The Trade Desk's version is its scope. Some companies limit repricings to non-executive employees, on the reasoning that the C-suite is better paid and has the most direct influence over the outcome that sank the options. Lions Gate took that approach in its own repricing a few years ago. The Trade Desk is including its C-suite. The people most responsible for the share-price outcome are among those whose underwater awards get reset.
The proxy does exclude one award: the CEO's October 2021 performance options are not eligible. That carve-out leads to the second weakness in the bullish reading.
Reloading a Package the Board Has Already Written
Special "dark arts" grants carry signal when they break pattern. That is the case when a board does something it does not normally do and ties a large, unusual award to a demanding stock-price hurdle. The new Trade Desk package requires the stock to reach $105 for full vesting. From about $12, that is roughly 8.7 times the current price over a ten-year term. As a hurdle, it is demanding.
It is also the second time this board has written the same kind of grant. In October 2021, with the stock around $68.29, the CEO received a ten-year performance option package built on escalating price hurdles. A board that issues stock-price-heavy mega-grants on a schedule is showing a compensation philosophy. It is not revealing private information about where the stock is going.
The two packages also differ in ways that favor management:
- The relative-performance modifier is gone. The 2021 grant adjusted payouts for how the stock performed against the Nasdaq, so a market-wide rally could not carry the CEO to a full payout. The new grant drops that adjustment. A broad tech rebound now counts the same as company-specific outperformance.
- The vesting curve is front-loaded. The 2021 package vested equal share counts at each tranche. The new one places more shares at the lower hurdles, which are easier to hit. The $105 headline makes the grant look demanding, but more of its economic value sits at the bottom of the ladder.
Taken together with the repricing, the structure is easy to see. Old underwater awards for executives get reset. A new grant concentrates value at the most reachable price levels. Only the 2021 CEO award, which is probably too far underwater to matter soon, is left as is. Each move on its own can be defended as retention. Combined, they protect management's compensation across most stock-price outcomes.
The $150 Million Check, Net of the Billion
The strongest piece of bull evidence is not the option grant. It is the CEO's open-market purchase earlier this year, reported at about $150 million, which ranks among the largest insider buys on record. Purchases are paid in cash at market prices, and insiders who buy that heavily are putting real money behind their judgment. The buy was made at roughly twice today's price, in the $20s, so it is now deeply underwater as well.
The context weakens it. By the same commentator's count, the CEO sold more than $1 billion of stock over the preceding years, mostly in the $80 to $120 range. Buying back a fraction of that at a fifth of the exit price is a strong trade. It is a smaller statement of conviction than the dollar figure implies. An insider who has already realized gains several times larger than the new purchase, and whose board keeps reloading his options, has much less at stake in a $150 million position than the headline suggests.
This is the one link in the argument that is truly uncertain. Selling high and buying low could reflect good valuation instincts and real conviction about the current discount. It could also reflect portfolio management by someone whose downside is cushioned elsewhere. The filings cannot tell these apart. What the filings do show is that the cushion exists and is getting thicker.
What the Bull Gets Right
The countercase deserves a fair hearing, and it has substance. The business is not in distress. Per the FY2025 balance sheet, the company held $658.2 million of cash against $436.3 million of total debt, a net cash position of about $222 million. Capex was a modest 6.8% of revenue and 19.8% of operating cash flow, lower relative to cash generation than Criteo (33.0%) or LiftOff (30.7%). Operating margin of 20.3% compares with 10.4% at Criteo, though standardized statements across ad-tech business models should be compared with caution.
The cash flow statement also shows that dilution was not ignored. Net common stock issuance was negative $1.31 billion in FY2025, meaning the company retired far more stock than it issued and spent about 1.65 times its free cash flow doing so. That is aggressive offsetting of the compensation program. The exact average repurchase price is not summarized here. Given where the stock traded through 2025, though, much of that $1.31 billion was likely spent at prices well above $12. The buyback did more to neutralize past dilution than to buy cheap equity. With the share price now a fraction of last year's levels, the same dollar compensation budget requires buying back far more shares to hold the share count flat, and the cash cushion of $658 million does not support another year of $1.3 billion in net repurchases.
The bull's conclusion, that the stock can work from here, may well be right. A stock down this much, with net cash and nearly $800 million of annual free cash flow, gives a lot of room for the price to recover. Even the skeptical commentator expects it to perform well. The claim being made here is narrower: the compensation package should not be counted as evidence for that outcome.
The Number That Settles It
The decision variable is not the $105 hurdle. It is the dollar value of stock compensation in the next annual report, read against the repricing vote. If the board resets strikes and also cuts the dollar value of new grants to reflect a company worth a fraction of its former value, SBC falls well below FY2025's $490.6 million and the 5.4% owner-earnings yield starts moving toward the 14% headline. In that case, the CEO's options regain some signal, because they would be surrounded by restraint rather than reload.
If SBC holds near half a billion dollars while the repricing passes with the C-suite included, the read is clear. Shareholders are financing a compensation program that wins in a rally and gets made whole in a collapse. The option grant then describes the board's policy, not its forecast.
